Significant numbers of patients die each year from malignant disease.
The question of whether or not to administer artificial hydration ther
apy to the patient who is in the last few days of life has been discus
sed for some time. Some health care professionals contend that a reduc
ed fluid intake, which often accompanies the dying process, may result
in a potentially painful and distressing state of dehydration, requir
ing preventative measures of fluid replacement therapy. In contrast, o
ther clinicians suggest that artificial hydration is often of no prove
n benefit in the context of the dying and may impose additional physic
al and psychological burdens on the patient. This paper investigates t
he advantages and disadvantages of artificial hydration therapies in t
erms of the symptom distress experienced by the terminally ill cancer
patient. Its aim is to promote discussion about this vital aspect of p
atient care.